The epicentre of this selling is of course the United States, home to many of the world's largest pharmaceutical companies, and the stage on which most of the action in this book takes XII Prologue place. [...] That influence is fundamentally distorting medical science, corrupting the way medicine is XIV Prologue practised, and corroding the public's trust in their doctors.14 The burying of unfavourable research studies on children and antidepressants, the dangers of the anti-arthritis drugs and the investigations into the alleged bribing of physicians in Italy and the US are just the latest in a string [...] Clearly, the wider you draw the boundaries that define a disease, the wider the pool of potential patients, and the bigger the markets for those making drugs. [...] Already, one of the statins, Bayer's Baycol, has been pulled from the market after being implicated in several cases of death.4 The newest statin, AstraZeneca's Crestor, has also faced calls for its withdrawal, because of very rare but debilitating side effects of muscle wasting and kidney failure.5 O 1 The dawn of the new age of cholesterol came in 1987, when Merck launched the first of the stati [...] Sponsoring advocacy groups that tend to keep messages simple, and keep the focus on the fear of high cholesterol, will inevitably help to maximise the sales of cholesterol-lowering drugs.40 Up at White River Junction, set amongst the green mountains of Vermont in the north east of the US, the fear-mongering around cholesterol is starting to unsettle practising physicians like Dr Lisa Schwartz.
Authors
- Bibliography, etc. Note
- Includes bibliographical references and index
- Control Number Identifier
- CaOOCEL
- Dewey Decimal Classification Number
- 381/.456151
- General Note
- Issued as part of the desLibris books collection
- ISBN
- 9781926706689 9781553651314
- LCCN
- HD9665.5
- LCCN Item number
- M69 2005eb
- Modifying agency
- CaBNVSL
- Original cataloging agency
- CaOONL
- Physical Description | Extent
- 1 electronic text (xx, 254 p.)
- Published in
- Canada
- Publisher or Distributor Number
- CaOOCEL
- Rights
- Access restricted to authorized users and institutions
- System Control Number
- (CaBNVSL)slc00212054 (OCoLC)456139513 (CaOOCEL)416882
- System Details Note
- Mode of access: World Wide Web
- Transcribing agency
- CaOONL
Table of Contents
- Contents 6
- Introduction 8
- Prologue: Selling sickness 12
- 1. Selling to everyone: High cholesterol 22
- 2. Doughnuts for the doctors: Depression 43
- 3. Working with celebrities: Menopause 62
- 4. Partnering with patients: Attention deficit disorder 82
- 5. Making risks into medical conditions: High blood pressure 103
- 6. Advertising disease: Pre-menstrual dysphoric disorder 120
- 7. Shaping public perceptions: Social anxiety disorder 140
- 8. Testing the markets: Osteoporosis 160
- 9. Taming the watchdogs: Irritable bowel syndrome 177
- 10. Subverting the selling: Female sexual dysfunction 196
- Epilogue: What can we do? 217
- Notes 222
- Acknowledgements 263
- Index 267
- A 267
- B 268
- C 268
- D 269
- E 269
- F 270
- G 270
- H 270
- I 271
- J 271
- K 271
- L 271
- M 271
- N 272
- O 272
- P 272
- R 273
- S 273
- T 274
- U 274
- V 274
- W 274
- Z 275
